Click here for slides on this topic


ADA Guidelines

Published annually in the journal Diabetes Care, the American Diabetes Association (ADA) guidelines are diabetes-related clinical practice recommendations covering diabetes diagnosis, diabetes treatment, and diabetes management.
The following content matched the glossary term: ADA Guidelines

AHA ADA prevention of CVD in T2D - Hypoglycemia & CVD

Top

Summary of evidence for hypoglycemia & cardiovascular disease (CVD) from the AHA ADA CVD prevention in type 2 diabetes guidelines.

AHA ADA prevention of CVD in T2D - Kidney Disease

Top

Summary of recommendations for management of kidney disease from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

AHA ADA prevention of CVD in T2D - Aspirin Therapy

Top

Summary of recommendations for aspirin therapy from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

AHA ADA prevention of CVD in T2D - Cholesterol Management

Top

Summary of cholesterol management recommendations from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

AHA ADA prevention of CVD in T2D - Blood Pressure Management

Top

Summary of blood pressure target recommendations from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

AHA ADA prevention of CVD in T2D - Glycemic Targets

Top

Summary of glycemic target recommendations, including A1C goals, from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

AHA ADA prevention of CVD in T2D - Metabolic Bariatric Surgery for Weight Management

Top

Summary of recommendations for bariatric surgery for obese patients from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

AHA ADA prevention of CVD in T2D - Pharmacologic Therapy for Weight Management

Top

Summary of pharmacologic therapy options for weight loss from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

AHA ADA prevention of CVD in T2D - Lifestyle Management

Top

Summary of lifestyle management recommendations from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

AHA ADA prevention of CVD in T2D - Diabetes Diagnosis

Top

Summary of criteria for diabetes diagnosis from the AHA ADA cardiovascular disease (CVD) prevention in type 2 diabetes guidelines.

1 2 3 4 5 6 Next 

Slide Library Results

Search Results for: ADA Guidelines Slides Found: 76
Recommended Treatment of Hypertension in Diabetes
ADA/AHA/ACC: Recommendations for Use of Aspirin for Primary Prevention of CV Events in People With Diabetes
STAMPEDE: Design
Type 1 Diabetes Diagnosis Follow-Up ADA Guidelines | NDEI PPT
AHA ADA Guidelines Diabetes CVD PPT | NDEI
Lifestyle for Weight Loss in Diabetes AHA ADA Guidelines | NDEI
A1C Targets AHA ADA Guidelines Type 2 Diabetes CVD Prevention | NDEI
Type 2 Diabetes & CVD Risk AHA ADA Guidelines PPT | NDEI
Blood Pressure Targets Type 2 Diabetes AHA ADA Guidelines | NDEI
Cholesterol Targets LDL Type 2 Diabetes AHA ADA Guidelines | NDEI
Cognitive Dysrunction in Type 2 Diabetes ADA Guidelines | NDEI PPT
Criteria for Type 2 Diabetes Diagnosis ADA Guidelines 2016 | NDEI PPT
Prediabetes Increases Type 2 Diabetes Risk ADA Guidelines | NDEI PPT
Type 1 Diabetes Screening ADA Guidelines 2016 | NDEI PPT
Gestational Diabetes Mellitus (GDM) Diagnosis ADA Guidelines | NDEI PPT
Type 2 Diabetes and Prediabetes Screening for Children ADA Guidelines | NDEI
Diagnosing Gestational Diabetes Mellitus GDM ADA Guidelines | NDEI PPT
Glycemic Targets in Pregnancy ADA Guidelines 2016 | NDEI PPT
Diabetes Comorbities ADA Guidelines | NDEI PPT
Fatty Liver Disease Is A Diabetes Comorbidity ADA Guidelines | NDEI
Sleep Apnea Is A Diabetes Comorbidity ADA Guidelines | NDEI
Cancer Is A Diabetes Comorbidity ADA Guidelines | NDEI PPT
Fractures Are A Diabetes Comorbidity ADA Guidelines | NDEI
Low Testosterone Is A Comorbidity of Diabetes ADA Guidelines | NDEI
Hearing Impairment Is A Diabetes Comorbidity ADA Guidelines | NDEI
Cognitive Impairment & Diabetes ADA Guidelines Slide | NDEI
Diabetes Self-Management Education DSME ADA Guidelines | NDEI
Medical Nutrition Therapy in Diabetes 2016 ADA Guidelines | NDEI PPT
Physical Activity in Patients With Diabetes Complications ADA Guidelines | NDEI
Psychosocial Assessment and Care in Type 2 Diabetes ADA Guidelines | NDEI
Vaccines in Patients With Type 2 Diabetes ADA Guidelines | NDEI PPT
Type 2 Diabetes Prevention ADA Guidelines 2016 | NDEI PPT
Self-Monitoring of Blood Glucose (SMBG) in Diabetes ADA Guidelines | NDEI
Continuous Glucose Monitoring (CGM) Insulin Type 2 Diabetes ADA Guidelines | NDEI
Frequency of A1C Testing for Diabetes Diagnosis ADA Guidelines | NDEI
Glycemic Targets for Adults With Diabetes A1C ADA Guidelines | NDEI
Individualized Glycemic Targets in Diabetes ADA Guidelines 2016 | NDEI
Managing Hypoglycemia in Diabetes ADA Guidelines 2016 | NDEI PPT
Type 1 Diabetes Treatment Options ADA Guidelines 2016 | NDEI PPT
Pharmacologic Therapy for Type 2 Diabetes ADA Guidelines | NDEI PPT
Type 2 Diabetes Treatment Algorithm ADA Guidelines 2016 | NDEI PPT
Strategies for Insulin Use in Type 2 Diabetes ADA Guidelines | NDEI PPT
Treatment for Overweight & Obesity in Type 2 Diabetes ADA Guidelines | NDEI
Obesity Treatment Options Type 2 Diabetes ADA Guidelines | NDEI PPT
Bariatric Surgery in Type 2 Diabetes ADA Guidelines | NDEI PPT
Hypertension Treatment Options in Diabetes ADA Guidelines | NDEI PPT
Lifestyle Changes for Hypertension in Diabetes ADA Guidelines | NDEI PPT
Statin Therapy in Type 2 Diabetes ADA Guidelines 2016 | NDEI PPT
Combination Statin Therapy in Type 2 Diabetes ADA Guidelines | NDEI PPT
Statin Therapy Recommendations for Type 2 Diabetes ADA Guidelines | NDEI
Statins & Diabetes Risk ADA Guidelines 2016 | NDEI PPT
Antiplatelet Therapy Recommendations ADA Guidelines | NDEI PPT
Retinopathy Screening Recommendations ADA Guidelines | NDEI PPT
ADA Guidelines for Retinopathy Treatment 2016 | NDEI PPT
Foot Care in Patients With Diabetes ADA Guidelines | NDEI PPT
Diabetes Care for Older Adults ADA Guidelines 2016 | NDEI PPT
Glycemic Targets for Children With Type 1 Diabetes ADA Guidelines | NDEI
2016 ADA Guidelines for Treating Hypertension in Children With Type 1 Diabetes | NDEI
ADA Guidelines for Treating Dyslipidemia in Children With Type 1 Diabetes | NDEI
ADA Guidelines Treating Microvascular Complications in Children With Type 1 Diabetes | NDEI
Pregestational Diabetes Recommendations ADA Guidelines | NDEI PPT
Management of Pregestational Diabetes ADA Guidelines | NDEI PPT
ADA Guidelines for Gestational Diabetes (GDM) 2016 | NDEI PPT
Postpartum Follow-Up for Women With Gestational Diabetes ADA Guidelines | NDEI
Managing Hypertension During Pregnancy ADA Guidelines | NDEI PPT
Glycemic Targets for Critically Ill Patients ADA Guidelines | NDEI PPT
Perioperative Care of Critically Ill Patients With Diabetes ADA Guidelines | NDEI
Cystic Fibrosis-Related Diabetes ADA Guidelines | NDEI PPT
Monogenic Diabetes Syndromes Diagnosis in Children ADA Guidelines | NDEI
Diabetic Kidney Disease Screening & Treatment ADA Guidelines | NDEI PPT
Vaccines in Patients With Type 2 Diabetes ADA Guidelines | NDEI PPT
Managing Diabetic Kidney Disease ADA Guidelines 2016 | NDEI PPT
Blood Pressure Treatment Targets in Diabetes ADA Guidelines | NDEI PPT
Lifestyle Changes for Obesity Management ADA Guidelines | NDEI PPT
Correlation of A1C With Average Glucose ADA Guidelines | NDEI PPT
Type 2 Diabetes & Prediabetes Screening ADA Guidelines | NDEI PPT